Next-generation platform now offers deeper tissue access and enhanced procedural efficiency for physicians Malvern, PA (March 17, 2026) – Trice Medical today announced nationwide commercial availability
Tenex® 2nd Generation: FDA Clears the Next Innovation in Tenex Technology Malvern, PA (December 4, 2024) – Trice Medical has received FDA 510(k) Clearance for
Malvern, PA (October 26, 2021) – Trice Medical has received FDA 510(k) Clearance for 25-degree mi-eye 3 needlescope™ with distinctive horizon leveling technology, clearing the way for
Malvern, PA (August 26th, 2021) – Trice Medical announced today that it received a strategic investment from Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for
Malvern, PA (May 24th, 2021) – Trice Medical announced today the appointment of Ryan Hartman as Chief Commercial Officer. Mr. Hartman brings with him over
Trice Medical continues mission of making elective procedures more efficient through the acquisition of Tenex Health. Malvern, PA (April 1st, 2021) – Trice Medical announced
MALVERN, Pa. (August 13, 2019) –Trice Medical, a leader in cutting-edge technology for minimally invasive orthopedic procedures, today announced that it is Great Place to
